1. Autophagy activation ameliorates the fibrosis of trabecular meshwork cells induced by TGFβ2 through the promotion of fibrotic proteins degradation.
- Author
-
Wang G, Zhao R, Guo Z, Cui H, Wang D, Ren J, Zhu S, Zhang K, Tang B, Zhang J, Li P, Duan S, and Li H
- Subjects
- Humans, Animals, Proteolysis, Everolimus pharmacology, Cells, Cultured, Glaucoma pathology, Glaucoma metabolism, Gene Expression genetics, Smad3 Protein metabolism, Signal Transduction, Chloroquine pharmacology, Intraocular Pressure, Autophagy genetics, Autophagy drug effects, Trabecular Meshwork metabolism, Trabecular Meshwork pathology, Transforming Growth Factor beta2 metabolism, Sirolimus pharmacology, Fibrosis
- Abstract
The level of transforming growth factor-beta2 (TGFβ2) is elevated in aqueous humor of partial glaucoma patients, and induced trabecular meshwork (TM) fibrosis, which could cause TM cells dysfunction and lead to intraocular pressure (IOP) elevation. Autophagy is a dynamic process of bulk degradation of organelles and proteins under stress condition, while its functions in fibrotic development remain controversial. Meanwhile, it is still unclear if activation of autophagy could ameliorate TGFβ2-induced fibrosis in TM cells. In this study, we demonstrated that autophagy activation with Rapamycin or Everolimus could ameliorate TM fibrosis induced by TGFβ2. We also proved that activation of autophagy may decrease TM cells fibrosis and reduce elevated IOP induced by TGFβ2 in vivo, while Rapamycin or Everolimus has no effect on TGFβ/Smad3 pathway activity and fibrotic genes expression. However, when Chloroquine phosphate blocks autophagy-lysosome pathway, the protective effect of Rapamycin or Everolimus on fibrosis was weakened. We established that autophagy activation ameliorates TM fibrosis through promoting fibrotic proteins degradation., (© 2024. The Author(s) under exclusive licence to Japan Human Cell Society.)
- Published
- 2024
- Full Text
- View/download PDF